(SANA) Sana Biotechnology - Performance -37.3% in 12m
SANA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-82.91%
#146 in Peer-Group
Rel. Strength
13.28%
#6656 in Stock-Universe
Total Return 12m
-37.33%
#115 in Peer-Group
Total Return 5y
-90.91%
#117 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 6.86 USD |
| 52 Week Low | 1.34 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.06 |
| Buy/Sell Signal +-5 | 2.17 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SANA (-37.3%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: SANA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SANA
| Total Return (including Dividends) | SANA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 37.50% | 3.36% | 5.25% |
| 3 Months | 115.54% | 15.73% | 24.13% |
| 12 Months | -37.33% | -7.02% | 14.15% |
| 5 Years | -90.91% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | SANA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 51.6% | 4.4% | 81% |
| 3 Months | 92.8% | 78.8% | 96.9% |
| 12 Months | -76.6% | -85.8% | 44.9% |
| 5 Years | -77.5% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th93.50 | 33.04% | 30.65% |
| 3 Month | %th96.50 | 86.24% | 73.64% |
| 12 Month | %th43.50 | -32.59% | -45.10% |
| 5 Years | %th47.00 | -82.68% | -94.73% |
FAQs
Does Sana Biotechnology (SANA) outperform the market?
No,
over the last 12 months SANA made -37.33%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months SANA made 115.54%, while XBI made 15.73%.
Performance Comparison SANA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SANA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 11.8% | 32.3% | 76.6% | -51% |
| US NASDAQ 100 | QQQ | 12% | 32.2% | 76% | -50% |
| German DAX 40 | DAX | 14% | 38.9% | 64.5% | -66% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 12% | 34.3% | 73.2% | -57% |
| Hongkong Hang Seng | HSI | 12.2% | 31.4% | 57.2% | -76% |
| India NIFTY 50 | INDA | 13.7% | 34% | 76.3% | -37% |
| Brasil Bovespa | EWZ | 9.4% | 28.7% | 51.6% | -47% |
SANA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 13.2% | 31.6% | 72.5% | -62% |
| Consumer Discretionary | XLY | 12.3% | 34.3% | 84.3% | -55% |
| Consumer Staples | XLP | 11.5% | 36.9% | 75% | -46% |
| Energy | XLE | 11.5% | 30.4% | 80.7% | -37% |
| Financial | XLF | 11.1% | 32.4% | 71.7% | -67% |
| Health Care | XLV | 12.4% | 35.4% | 84% | -33% |
| Industrial | XLI | 11.7% | 33.3% | 68.8% | -62% |
| Materials | XLB | 9.6% | 33.2% | 72.1% | -43% |
| Real Estate | XLRE | 11.9% | 36.5% | 76.9% | -50% |
| Technology | XLK | 11.1% | 28.8% | 74.3% | -48% |
| Utilities | XLU | 12.9% | 35.7% | 73.4% | -60% |
| Aerospace & Defense | XAR | 13.9% | 30.4% | 58.1% | -87% |
| Biotech | XBI | 10.8% | 34.1% | 89.8% | -30% |
| Homebuilder | XHB | 9.3% | 30.5% | 83.8% | -43% |
| Retail | XRT | 9.3% | 32.5% | 80.9% | -49% |
SANA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 10.9% | 29.1% | 85.0% | -30% |
| Natural Gas | UNG | 21.3% | 47.3% | 93.4% | -35% |
| Gold | GLD | 11.6% | 38.7% | 56% | -76% |
| Silver | SLV | 10.8% | 30.6% | 59.3% | -55% |
| Copper | CPER | 12.8% | 32.9% | 59.6% | -48% |
SANA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 13.6% | 36.5% | 80.1% | -35% |
| iShares High Yield Corp. Bond | HYG | 13% | 35.9% | 77.7% | -47% |